Document is current
Any future updates will be listed below
-
Authors
Lillpers, Kerstin https://orcid.org/0009-0006-0811-8232
Andréasson, Kristofer https://orcid.org/0000-0001-7021-2541
Najibi, Seyed Morteza https://orcid.org/0000-0001-6756-508X
Woolf, Anthony D https://orcid.org/0000-0001-8482-8056
Hesselstrand, Roger https://orcid.org/0000-0001-6794-2201
Åkesson, Kristina E https://orcid.org/0000-0003-3024-2804
Kapetanovic, Meliha C https://orcid.org/0000-0002-7853-514X
-
Funding
Funding for this research was provided by:
Lund University
- License Information
-
More Information
Article History
Received: 12 May 2026
Accepted: 24 August 2026
First Online: 1 September 2026
Declarations
Ethics approval and consent to participate: The study was approved by the Swedish Ethical Review Authority (EPN Lund Dnr. 590/2008 and 2016/129) and is in accordance with the Helsinki declaration. All participants provided written informed consent.
Consent for publication: Not applicable.
Competing interests: Kerstin Lillpers, Sayed Morteza Najibi, Anthony D Woolf, Meliha C Kapetanovic: The author declare that they have no competing interests. Kristofer Andréasson: Speaker bureau; Johnson & Johnson. Roger Hesselstrand: Employee at Boehringer Ingelheim. Kristina E Åkesson: Lecture fees Amgen, Astellas Pharma, About Science Srl, Medac, Sandoz, UCB.
